Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Multiple sclerosis : actuality and therapeutic prospects].
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Multiple sclerosis and progressive resistance training: a systematic review.
Acorda Therapeutics announces positive AMPYRA® (dalfampridine) Phase 2 data in people with post-stroke deficits
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Depakote: No Prescription Cheap Low
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
B-07The Cognitive Health Questionnaire: Initial Psychometric Data in a Multisite Multiple Sclerosis Sample.
UW-SES: A new self-efficacy scale for people with disabilities.
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Cortical lesion load associates with progression of disability in multiple sclerosis.
The American Academy of Neurology's Top Five Choosing Wisely recommendations.

Pages